4-[(6-chloro-3-pyridinyl)methyl]morpholine, 95.0%, 100mg

2-(tert-Butyl) 3-ethyl 2,8-diazaspiro[4.5]decane-2,3-dicarboxylate, 97.0%, 250mg

3-Iodo-1-[(1-methyl-4-piperidinyl)methyl]-1H-pyrazolo[3,4-d]pyrimidin-4-amine, 97%, 1g

Filtration unit with cellulose nitrate membrane Pore size 0.45 μm, with grid, 250 ml, 250 ml, 50 mm, 12 Piece(s)

4'-Nitrobenzo-18-crown 6-Ether>97.0%(GC)1g

4-Chloro-3-methylaniline, 98.0%, 25g

2,4-Bis[(dodecylthio)methyl]-6-methylphenol>95.0%(GC)500g

4-Bromo-1-(bromomethyl)-2-methylbenzene, 95.0%, 500mg

3,4-Dichlorophenylacetic acid, 98.0%, 500g

(R)-(3-(3-Fluoro-4-morpholinophenyl)-2-oxooxazolidin-5-yl)methyl methanesulfonate, 95.0%, 5g

3-((Dimethylamino)methyl)benzoic acid, 95.0%, 5g

2-CHLORO-5-(METHYLSULFONYL)PYRIDINE, 95.0%, 1g

Dialysis systems Spectra/Por® Float-A-Lyzer® G2 Filling volume 10 ml, 3500–5000 dalton(s), 12 Piece(s)